Bioorganic and Medicinal Chemistry Letters p. 2371 - 2376 (1996)
Update date:2022-09-26
Topics:
Hoekstra, William J.
Maryanoff, Bruce E.
Andrade-Gordon, Patricia
Cohen, Judith H.
Costanzo, Michael J.
Damiano, Bruce P.
Haertlein, Barbara J.
Harris, Bruce D.
Kauffman, Jack A.
Keane, Patricia M.
McComsey, David F.
Villani Jr., Frank J.
Yabut, Stephen C.
A study of β-turn peptide mimetics, related to the C-terminal γ-chain of fibrinogen and containing a nipecotic acid scaffold, led to RWJ-50042 (1), an interesting fibrinogen receptor (GPIIb/IIIa) antagonist. To enhance potency, we employed solid-phase parallel synthesis for the preparation of over 200 analogues in a protocol of optimization cycles. This strategy produced several promising nipecotamide analogues, such as 25, which is 35 times more potent than 1 in vitro.
View MoreLonghui qunfeng Chemical Co., Ltd
Contact:86-731-82173407
Address:South-east Industrial Park, Longhui County, Hunan Province, China
Chengdu Green Young Biopharmaceutical INC
Contact:+86-28-85337952
Address:1-B-26,Tianhe Industry Park, No.1480 of Tianfu Road,Chengdu,P.R.China,610000
Wuhan Kemi-Works Chemical Co., Ltd
website:http://www.kemiworks.com
Contact:86-27-85736489
Address:Rm. 1503, No. 164, Jianghan North Rd., Wuhan, 430022 China
Heliosense Biotechnologies, Inc.
website:https://www.heliosense.com/
Contact:+86-592-5667290
Address:Xiamen Torch Hi-tech Zone Venture Weiye Building S506
Tianjin Tongde Biological Technology Co., Ltd.
Contact:86-22-23309138
Address:Room 402, bulidingE3 Detection certification park, XiQingDistrict, Tianjin City
Doi:10.1055/s-2007-970774
(2007)Doi:10.1248/cpb.29.1912
(1981)Doi:10.1016/S0040-4020(01)97951-7
(1981)Doi:10.1016/S0040-4039(01)81769-X
(1981)Doi:10.1246/bcsj.54.2223
(1981)Doi:10.1021/ma401010t
(2013)
